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1. Introduction 
Parathyroid hormone (PTH) promotes adenylate 
cyclase activity in renal cortex [ 1,2] leading to an 
increased concentration of cyclic adenosine 3’S’-mono- 
phosphate (CAMP) in renal parenchymal cells [3,4]. 
This cyclic nucleotide is proposed as an intermediate 
in the action of PTH [ 1,2,4,5]. In the present 
experiments a study was made of the effects of 
diphosphonates and pyrophosphate on adenylate 
cyclase activity, since pyrophosphate is an end- 
product of the reaction. Diphosphonates are com- 
pounds related to pyrophosphate, but contain P-C-P 
bonds instead of the P-O-P bond of pyrophosphate 
[6]. They are extremely resistent to chemical and 
enzymatic hydrolysis [6,7], but otherwise have many 
of the properties of pyrophosphate [6-g]. 
2. Methods 
Adenylate cyclase preparations were made from 
kidney cortex essentially by the method of Marcus 
and Aurbach [ lo], modified by including 4.5 mM 
MgCl, and 30 mM KC1 in the homogenizing medium 
(0.05 M Tris-HCl, pH 7.4, containing 10% dimethyl- 
sulfoxide). Adenylate cyclase activity was assayed by 
measuring the formation of 32P-labelled CAMP from 
(e”2P) ATP in incubations which contained the fol- 
lowing in a total volume of 80 d: 50 mM Tris,HCl, 
pH 7.4; 0.5 mM (cY-~~P) ATP (specific activity approx. 
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20 cpm per pmole); 1 mM CAMP; 0.013% BSA; 
30 mM KCl; 4.5 mM MgCl,; phosphoenolpyruvate 
2.5 mM; pyruvate kinase 1.5 I.U.; 300 pg protein of 
the kidney cortex preparation, and test substances. 
After 10 min incubation the reaction was, stopped by 
adding excess ATP and boiling, and the method of 
Ramachandran [ 1l] was used to purify the generated 
cAM~~P. Using 3H-labelled CAMP, recoveries of 
80-95% were obtained, and the coefficient of varia- 
tion for the adenylate cyclase assay method deter- 
mined for each new batch of enzyme, varied from 3 
to 7%. 
(cx-~‘P) ATP and (3H) CAMP were purchased 
from the Radiochemical Centre, Amersham, U.K. 
Dichloromethylenediphosphonate (C12DP) and 
ethane-l-hydroxy-1,ldiphosphonate (EHDP) were 
kindly provided by Dr. M.D. Francis, Procter and 
Gamble Co., USA. All other chemicals were from 
standard suppliers. 
PTH was prepared in our laboratory by the method 
of Aurbach [ 121 to the stage of TCA precipitation. 
This preparation (TCA-PTH) had a potency of 
320 units per mg [lo]. 
3. Results 
Dichloromethylenediphosphonate and pyrophos- 
phate inhibited fluoride- and PTH-stimulated adenyl- 
ate cyclase activity. Table 1 shows the r sults of an 
experiment in which pyrophosphate inhibition was 
virtually complete at 10 mM, and at 1 mM was only 
slightly greater than the inhibition produced by 
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Table 1 
August 1972 
Effects of dichloromethylenediphosphonate (ClaDP) and pyrophosphate on NaF- and PTH-stimulated kidney adenylate cyclase 
activity (pmoles CAMP formed in 10 min). 
C12DP Pyrophosphate 
Treatment Control 
0.2 mM 0.02 mM 10 mM 1 mM 
Nil 14 12 16 2 14 
12 Mg TCA-PTH 62 46 63 -I 42 
10 mM NaF 202 63 122 3 38 
12 TCA-PTH pg + 10 mM NaF 281 109 163 2 48 
.~___ __- 
Each result represents the mean of triplicate determinations, individual results varied by no more than 10% from the mean. 
l-_-__ 
0.5 1-o l-5 2-o 2-s 
Units of PTH activity 
Fig. 1. Effects of 1 mM pyrophosphate ( a) and 0.35 mM 
dichloromethylenediphosphonate (-4) on PTH-stimulated 
kidney adenylate cyclase activity compared with control 
(w). Results shown represent the mean of triplicate 
determinations; individual results varied by no more than 10% 
from the mean. 
0.2 mM Cl, DP. Both the diphosphonate and pyro- 
phosphate influenced the fluoride- to a greater extent 
than the hormone-stimulated activity. 
PTH and fluoride effects were found to be additive. 
In incubations in which fluoride stimulation was in- 
hibited by pyrophosphate or Cl,DP, PTH was able to 
increase further the adenylate cyclase activity. In all 
experiments the concentration of diphosphonate 
required for inhibition was less than that of pyro- 
phosphate. An example is given in fig. 1, showing the 
response to three dose levels of PTH in the presence 
of pyrophosphate and CI,DP. 
The results in table 2 show that quantitative 
responses varied with different diphosphonates. Under 
most conditions studied, Cl,DP was significantly more 
effective than EHDP in inhibiting fluoride-stimulated 
adenylate cyclase activity. Similar results were obtained 
with PTH-stimulated enzyme activity. 
To determine whether CAMP could influence the 
enzyme activity, an experiment was carried out in 
which CAMP was omitted from the incubation 
medium, and theophylline (10 mM) used as a phos- 
phodiesterase inhibitor. Addition of CAMP up to 
4 mM had no effect on fluoride-stimulated adenylate 
cyclase activity, nor did it modify the inhibition 
produced by pyrophosphate (fig. 2). 
4. Discussion 
These experiments indicate that pyrophosphate, 
one of the products of the adenylate cyclase reaction, 
can influence the rate of CAMP accumulation, whereas 
the cyclic nucleotide itself appears to have no such 
effect. The fact that the pyrophosphate concentrations 
required to produce this effect are greater than the 
diphosphonate concentrations, may be explained by 
the presence of pyrophosphatase activity in the crude 
tissue preparations. Whereas pyrophosphate is 
susceptible to rapid enzymic hydrolysis, diphosphon 
ates are extremely resistant, The actual concentrations 
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Table 2 
Comparison of dichloromethylenediphosphonate (ClzDP) and ethane-1-hydroxy-1 ,l-diphosphonate (EHDP) effects on basal and 
fluoride-stimulated adenylate cyclase (pmoles CAMP formed; means f SEM; 4 determinations for each point). 
Treatment 
(0.03 mM) (0.3 mM) (1.5 mM) 
ClsDP EHDP p Cl2 DP EHDP p C12DP EHDP p 
Nil 24.9 16.1 20.4 NS 13.9 18.7 < 0.05 5.5 11.4 < 0.001 
*0.6 *0.9 il.3 kO.8 to.7 kO.6 *l.O 
NaF 375.4 239.2 290.2 NS 180.5 228.3 < 0.05 78.9 139.8 < 0.001 
(10 mM) i12.6 i6.0. k7.3 k2.3 +16.3 k4.1 +4.4 
Student’s “I” test was carried out to test for significant differences between response to each dose level of diphosphonate. 
(NS: not significant). 
of diphosphonates which were effective were small 
compared with the ATP (0.5 mM) in the incubations, 
and the inhibitory effects of pyrophosphate and 
diphosphonates cannot be explained by chelation of 
Mg ions, which are necessary for adenylate cyclase 
activity. 
It has been proposed that pyrophosphate and the 
diphosphonates produce their effects by physico- 
chemical means [9]. Diphosphonates have recently 
been found to reduce 45Ca efflux from mitochondria 
previously labelled with the isotope [ 131. Their in- 
fluence on the adenylate cyclase reaction is a further 
metabolic effect which may be of some general im- 
portance, particularly in view of the proposed use of 
diphosphonates in certain diseases in man [ 141. 
The recent demonstration [ 151 that pyrophosphate 
infusion in rats blocked the effects of PTH but not 
those of CAMP provide in vim evidence that pyro- 
phosphate may play a regulatory role at least in PTH- 
stimulated adenylate cyclase systems. 
-0mM. CAMP--)-O.EmM. CAMP-- 4mM CAMP --) 
Fig. 2. Effect of CAMP on fluoride-stimulated adenylate cyclase activity in kidney. Each test mixture contained 10 mM NaF. 
(0): No added pyrophosphate; (0): 1 mM pyrophosphate; (e): 2 mM pyrophosphate. Results shown represent he mean of tri- 
plicate determinations; individual results varied by no more than 10% from the mean. 
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